Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 12.61% vs 14.61% in Mar 2025
Standalone Net Profit
YoY Growth in year ended Mar 2026 is -60.08% vs 147.14% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 27.16% vs 8.08% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -20.32% vs -6.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Bajaj Healthcare With
Figures in Cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
611.03
93.99
517.04
550.10%
Other Operating Income
0.00
0.00
0.00
Total Operating income
611.03
93.99
517.04
550.10%
Raw Material Cost
306.20
0.00
306.20
Purchase of Finished goods
0.00
41.29
-41.29
-100.00%
(Increase) / Decrease In Stocks
10.20
-0.63
10.83
1,719.05%
Employee Cost
62.75
8.54
54.21
634.78%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
127.07
15.07
112.00
743.20%
Total Expenditure (Excl Depreciation)
506.21
64.27
441.94
687.63%
Operating Profit (PBDIT) excl Other Income
104.82
29.72
75.10
252.69%
Other Income
7.13
6.84
0.29
4.24%
Operating Profit (PBDIT)
111.95
36.56
75.39
206.21%
Interest
22.23
0.58
21.65
3,732.76%
Exceptional Items
-38.79
0.00
-38.79
Gross Profit (PBDT)
56.47
35.98
20.49
56.95%
Depreciation
27.55
2.75
24.80
901.82%
Profit Before Tax
28.92
33.23
-4.31
-12.97%
Tax
7.61
8.52
-0.91
-10.68%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
21.31
24.71
-3.40
-13.76%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
-5.54
0.00
-5.54
Net Profit
15.77
24.71
-8.94
-36.18%
Equity Capital
16.83
11.78
5.05
42.87%
Face Value
5.00
10.00
0.00
Reserves
516.17
313.93
202.24
64.42%
Earnings per share (EPS)
4.69
20.98
-16.29
-77.65%
Diluted Earnings per share
670.25
20.96
649.29
3,097.76%
Operating Profit Margin (Excl OI)
17.15%
31.62%
0.00
-14.47%
Gross Profit Margin
9.24%
38.28%
0.00
-29.04%
PAT Margin
3.49%
26.29%
0.00
-22.80%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 611.03 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 12.61% vs 14.61% in Mar 2025
Annual - Standalone Net Profit
Standalone Net Profit 15.77 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -60.08% vs 147.14% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 104.82 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 27.16% vs 8.08% in Mar 2025
Annual - Interest
Interest 22.23 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -20.32% vs -6.00% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.15%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025






